The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Invesco Health Care Y GGHYX
- NAV / 1-Day Return 41.13 / +1.03 %
- Total Assets 1.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.810%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield —
- Turnover 59%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:15 PM GMT+0
Morningstar’s Analysis GGHYX
Will GGHYX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 8.39 | 109.5 Mil | Healthcare |
UnitedHealth Group Inc | 7.78 | 101.5 Mil | Healthcare |
Boston Scientific Corp | 5.11 | 66.7 Mil | Healthcare |
McKesson Corp | 4.05 | 52.8 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 3.98 | 52.0 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 3.59 | 46.9 Mil | Healthcare |
Merck & Co Inc | 3.48 | 45.5 Mil | Healthcare |
Stryker Corp | 3.46 | 45.2 Mil | Healthcare |
Intuitive Surgical Inc | 3.21 | 41.9 Mil | Healthcare |
Zoetis Inc Class A | 3.14 | 41.0 Mil | Healthcare |